Atlas Trials

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

Clinical trial NCT03279081 · COMPLETED

Trial details

NCT number
NCT03279081
Sponsor
Tigenix S.A.U.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2017-09-15
Primary completion
2023-01-23
Enrollment
568

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.